Sunny Optical Technology (Group) Company Limited (FRA:SXC)

Intra-Cellular Therapies Statistics

Total Valuation

FRA:SXC has a market cap or net worth of EUR 8.60 billion. The enterprise value is 6.87 billion.

Market Cap	8.60B
Enterprise Value	6.87B

Important Dates

The next estimated earnings date is Friday, August 15, 2025.

Earnings Date	Aug 15, 2025
Ex-Dividend Date	Jun 5, 2025

Share Statistics

Current Share Class	1.09B
Shares Outstanding	n/a
Shares Change (YoY)	-0.34%
Shares Change (QoQ)	-0.16%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	658.55M

Valuation Ratios

The trailing PE ratio is 24.09 and the forward PE ratio is 21.08.

PE Ratio	24.09
Forward PE	21.08
PS Ratio	1.70
PB Ratio	2.57
P/TBV Ratio	2.64
P/FCF Ratio	47.40
P/OCF Ratio	18.82
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 12.76, with an EV/FCF ratio of 37.87.

EV / Earnings	19.24
EV / Sales	1.53
EV / EBITDA	12.76
EV / EBIT	24.79
EV / FCF	37.87

Financial Position

The company has a current ratio of 1.67, with a Debt / Equity ratio of 0.24.

Current Ratio	1.67
Quick Ratio	1.37
Debt / Equity	0.24
Debt / EBITDA	1.37
Debt / FCF	4.48
Interest Coverage	4.49

Financial Efficiency

Return on equity (ROE) is 11.53% and return on invested capital (ROIC) is 4.67%.

Return on Equity (ROE)	11.53%
Return on Assets (ROA)	2.69%
Return on Invested Capital (ROIC)	4.67%
Return on Capital Employed (ROCE)	7.14%
Revenue Per Employee	149,556
Profits Per Employee	10,541
Employee Count	33,884
Asset Turnover	0.74
Inventory Turnover	5.69

Taxes

In the past 12 months, FRA:SXC has paid 48.50 million in taxes.

Income Tax	48.50M
Effective Tax Rate	11.66%

Stock Price Statistics

The stock price has increased by +62.81% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+62.81%
50-Day Moving Average	7.46
200-Day Moving Average	7.94
Relative Strength Index (RSI)	50.47
Average Volume (20 Days)	364

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, FRA:SXC had revenue of EUR 5.07 billion and earned 357.18 million in profits. Earnings per share was 0.33.

Revenue	5.07B
Gross Profit	927.12M
Operating Income	296.85M
Pretax Income	415.99M
Net Income	357.18M
EBITDA	582.92M
EBIT	296.85M
Earnings Per Share (EPS)	0.33

Balance Sheet

The company has 2.83 billion in cash and 812.63 million in debt, giving a net cash position of 2.02 billion.

Cash & Cash Equivalents	2.83B
Total Debt	812.63M
Net Cash	2.02B
Net Cash Per Share	n/a
Equity (Book Value)	3.35B
Book Value Per Share	3.02
Working Capital	1.99B

Cash Flow

In the last 12 months, operating cash flow was 457.25 million and capital expenditures -275.74 million, giving a free cash flow of 181.51 million.

Operating Cash Flow	457.25M
Capital Expenditures	-275.74M
Free Cash Flow	181.51M
FCF Per Share	n/a

Margins

Gross margin is 18.30%, with operating and profit margins of 5.86% and 7.05%.

Gross Margin	18.30%
Operating Margin	5.86%
Pretax Margin	8.21%
Profit Margin	7.05%
EBITDA Margin	11.50%
EBIT Margin	5.86%
FCF Margin	3.58%

Dividends & Yields

This stock pays an annual dividend of 0.06, which amounts to a dividend yield of 0.71%.

Dividend Per Share	0.06
Dividend Yield	0.71%
Dividend Growth (YoY)	129.06%
Years of Dividend Growth	n/a
Payout Ratio	8.46%
Buyback Yield	0.34%
Shareholder Yield	1.05%
Earnings Yield	4.15%
FCF Yield	2.11%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

FRA:SXC has an Altman Z-Score of 2.9 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.9
Piotroski F-Score	7